Wells Fargo’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Wells Fargo’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,547	Closed	-$135K	–	7792
2023 Q4	$135K	Buy	8,547 +1,679	+24%	+$16.2K	﹤0.01%	4721
2023 Q3	$53.2K	Sell	6,868 -3,573	-34%	-$29.6K	﹤0.01%	5147
2023 Q2	$104K	Buy	10,441 +6,507	+165%	+$52.1K	﹤0.01%	5014
2023 Q1	$22.8K	Buy	+3,934	New	+$34K	﹤0.01%	5584
2022 Q4	–	Sell	-38	Closed	–	–	7815
2022 Q3	$0	Sell	38 -181	-83%	-$1.13K	﹤0.01%	7646
2022 Q2	$1K	Sell	219 -6,823	-97%	-$53.2K	﹤0.01%	6666
2022 Q1	$50K	Sell	7,042 -2,192	-24%	-$34.5K	﹤0.01%	5662
2021 Q4	$211K	Buy	9,234 +9,166	+13,479%	+$237K	﹤0.01%	5232
2021 Q3	$2K	Buy	+68	New	+$2.31K	﹤0.01%	6615

Wells Fargo's ICVX Position: Q1 2024 in Review

Wells Fargo sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 8,547 shares — an estimated $135K sold.

Wells Fargo first reported a position in ICVX in Q3 2021 and held it in 9 quarters. The position peaked at $211K in Q4 2021. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

Wells Fargo reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Wells Fargo sold 8,547 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $135K.
Wells Fargo first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 9 quarters.
Wells Fargo's Icosavax, Inc. Common Stock position peaked at $211K in Q4 2021.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.